HOME

Research

Teaching

Short Bio

Publications

Contact Information


Publications

2019
(15) Lyu, J.*; Wang, S.*; Balius, T. E.*; Singh, I.*.; Levit, A.; Moroz, Y. S.; O'Meara, M. J.; Algaa, E.; Tolmachova K.; Tolmachev, A. A.; Shoichet, B. K.; Roth, B. L.; and Irwin, J. J.; Ultra-large library docking for discovering new chemotypes. Nature 2019, 566, 224-229. doi.org/10.1038/s41586-019-0917-9. PMID: 30728502, PMCID:
* these authors contributed equally to this work.
Nature Editorial.
Nature News & Views.
Highlighted in Science.
2018
(14) Nnadi, C. I.; Jenkins, M. L.; Gentile, D. R.; Batemen, L. A.; Zaidman, D.; Balius, T. E.; Nomura, D. K.; Burke, J. E.; Shokat, K. M.; London, N.; Novel K-Ras G12C Switch-II covalent binders destabilize Ras and accelerate nucleotide exchange. J. Chem. Inf. Model. 2018, 58 (2), 464-471, doi:10.1021/acs.jcim.7b00399 , PMID: 29320178, PMCID: PMC6179444
2017
(12) Balius, T. E.*; Fischer, M.*; Stein, R. M.; Adler, T. B.; Nguyen C. N.; Cruz A.;Gilsonc M. K.; Kurtzman, T.; Shoichet, B. K., Testing inhomogeneous solvation theory in structure-based ligand discovery. Proc. Natl. Acad. Sci. USA. 2017, 114 (33) E6839-E6846, doi:10.1073/pnas.1703287114. PMID: 28760952, PMCID: PMC5565424
* these authors contributed equally to this work.
(13) Allen, W. J.*; Fochtman, B.C.*; Balius, T. E.; Rizzo, R. C., Customizable de novo Design Strategies for DOCK: Application to HIVgp41 and Other Therapeutic Targets. J. Comput. Chem. 2017, 38, 2641-2663, doi: 10.1002/jcc.25052. PMID: 28940386, PMCID: PMC5659719
2015
(9) Merski, M.*; Fischer, M.*; Balius, T. E.*; Eidam, O.; Shoichet, B. K., Homologous ligands accommodated by discrete conformations of a buried cavity. Proc. Natl. Acad. Sci. USA. 2015, 112 (16), 5039-5044, doi:10.1073/pnas.1500806112. PMID: 25847998, PMCID: PMC4413287
* these authors contributed equally to this work.
Highlighted in Science.

link to cover
(10) Allen, W. J.*; Balius, T. E.*; Mukherjee, S.; Brozell, S. R.; Moustakas, D. T.; Lang, P. T.; Case, D. A.; Kuntz, I. D.; Rizzo, R. C., DOCK 6: Impact of New Features and Current Docking Performance. J. Comput. Chem., 2015, 36 (15), 1132-1156, doi:10.1002/jcc.23905 . PMID: 25914306, PMCID: PMC4469538
* these authors contributed equally to this work.
(11) Teng, Y. G.; Berger, W. T.; Nesbitt, N. M.; Kumar, K.; Balius, T. E.; Rizzo, R. C.; Tonge, P.J.; Ojima, I.; Swaminathan, S., Computer-Aided Identification, Synthesis, and Biological Evaluation of Novel inhibitors for Botulinum Neurotoxin Serotype A. Bioorganic & Medicinal Chemistry, 2015, 23 (17), 5489-5495, doi:10.1016/j.bmc.2015.07.040. PMID: 26275678
2013

link to cover
(8) Balius, T. E.*; Allen, W. J.*; Mukherjee, S.; Rizzo, R. C., Grid-Based Molecular Footprint Comparison Method for Docking and De Novo Design: Application to HIVgp41. J. Comput. Chem., 2013, 34 (14), 1226-1240, doi:10.1002/jcc.23245 . PMID: 23436713, PMCID: PMC4016043
* these authors contributed equally to this work.
2012
(6) Brozell, S. R.; Mukherjee, S.; Balius, T. E.; Roe, D. R.; Case, D. A.; Rizzo, R. C. Evaluation of DOCK 6 as a Pose Generation and Database Enrichment Tool. J. Comput-Aided Mol Des, 2012, 26 (6), 749-773, doi:10.1007/s10822-012-9565-y . PMID: 22569593, PMCID: PMC3902891
(7) Berger, W. T.; Ralph, B. P.; Kaczocha, M.; Sun, J.; Balius, T. E.; Rizzo, R. C.; Haj- Dahmane, S.; Ojima, I.; Deutsch, D. G., Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters - A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs. PLOS One, 2012, 7 (12) e50968 doi:10.1371/journal.pone.0050968 . PMID: 23236415, PMCID: PMC3517626
2011
(5) Balius, T.E.; Mukherjee S.; Rizzo, R. C. Implementation and Evaluation of a Docking-Rescoring Method using Molecular Footprint Comparisons. J. Comput. Chem., 2011, 32(10), 2273-2289, doi:10.1002/jcc.21814 PMID: 21541962, PMCID: PMC3181325
2010
(2) Owonikoko T. K.; Ramalingam S. S.; Kanterewicz B.; Balius T. E.; Belani C. P.; Hershberger P. A. Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells. International Journal of Cancer 2010 126, 743-755, doi:10.1002/ijc.24759 . PMID: 19621389, PMCID: PMC2795066
(3) McGillick, B. E.*; Balius, T.E.*; Mukherjee, S.; Rizzo, R. C. Origins of Resistance to the HIVgp41 Viral Entry Inhibitor T20. Biochemistry, 2010, 49 (17), 3575-3592, doi:10.1021/bi901915g . PMID: 20230061, PMCID: PMC2867330
* these authors contributed equally to this work.
(4) Mukherjee S.; Balius, T.E.; Rizzo, R. C. Docking Validation Resources: Protein Family and Ligand Flexibility Experiments. J. Chem. Inf. Model., 2010, 50 (11), 1986-2000, doi:10.1021/ci1001982 . PMID: 21033739, PMCID: PMC3058392
2009
(1) Balius, T.E.; Rizzo, R. C. Quantitative Prediction of Fold Resistance for Inhibitors of EGFR. Biochemistry, 2009, 48 (35), 8435-8448, doi:10.1021/bi900729a . PMID: 19627157, PMCID: PMC2741091
Thesis
(0) Balius, T.E. Application and Development of Computational Tools in Drug Discovery, Ph.D Dissertation, Stony Brook University, 2012. PDF, proquest link

Google Scholar Profile
PUBMED
ORCID

modified: 2019/02/13